Subtopic Deep Dive
Immune Reconstitution Inflammatory Syndrome
Research Guide
What is Immune Reconstitution Inflammatory Syndrome?
Immune Reconstitution Inflammatory Syndrome (IRIS) is a paradoxical inflammatory response in HIV-infected patients initiating antiretroviral therapy (ART), unmasking or worsening underlying opportunistic infections like tuberculosis.
IRIS occurs in approximately one-quarter of patients starting highly active antiretroviral therapy (HAART), with dermatological manifestations predominant (Ratnam et al., 2006, 349 citations). TB-IRIS complicates HIV-TB coinfection, particularly in resource-limited settings (Pawłowski et al., 2012, 748 citations). Over 20 papers in the provided list address IRIS incidence, risk factors, and management.
Why It Matters
IRIS increases mortality risk in HIV-TB coinfected patients starting ART, complicating treatment in high-burden areas (Pawłowski et al., 2012). Ratnam et al. (2006) identified advanced immunodeficiency at HAART initiation as the greatest risk factor, affecting 25% of diverse cohorts. Murdoch et al. (2007) outlined treatment options like corticosteroids for severe cases, guiding clinical decisions in resource-limited settings where TB-HIV overlap burdens healthcare systems.
Key Research Challenges
Predicting IRIS Risk Factors
Advanced immunodeficiency at ART initiation heightens IRIS risk, but precise predictors remain elusive (Ratnam et al., 2006). Ethnic diversity complicates incidence modeling in cohorts (Ratnam et al., 2006, 349 citations). Distinguishing IRIS from new infections challenges diagnosis (Murdoch et al., 2007).
Timing ART in TB Coinfection
Optimal ART initiation timing after TB treatment prevents TB-IRIS but risks HIV progression (Pawłowski et al., 2012). Guidelines recommend symptom-based screening over cough alone (Cain et al., 2010). Balancing prophylaxis like isoniazid adds complexity (Nahid et al., 2016).
Corticosteroid Treatment Efficacy
Corticosteroids manage severe IRIS manifestations, but optimal dosing lacks consensus (Murdoch et al., 2007). Risks of immunosuppression in TB patients require verification (Solovič et al., 2010). Long-term outcomes in HIV-TB cohorts need further study.
Essential Papers
Tuberculosis and HIV Co-Infection
A Pawłowski, Marianne Jansson, Markus Sköld et al. · 2012 · PLoS Pathogens · 748 citations
Tuberculosis (TB) and HIV co-infections place an immense burden on health care systems and pose particular diagnostic and therapeutic challenges. Infection with HIV is the most powerful known risk ...
Intraocular Tuberculosis—An Update
Vishali Gupta, Amod Gupta, Narsing A. Rao · 2007 · Survey of Ophthalmology · 661 citations
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Ivan Solovič, Martina Sester, Juan J. Gómez‐Reino et al. · 2010 · European Respiratory Journal · 512 citations
Anti-tumour necrosis factor (TNF) monoclonal antibodies or soluble TNF receptors have become an invaluable treatment against chronic inflammatory diseases, such as rheumatoid arthritis, inflammator...
Macrophages and control of granulomatous inflammation in tuberculosis
JoAnne L. Flynn, John Chan, Philana Ling Lin · 2011 · Mucosal Immunology · 408 citations
Tuberculosis and HIV Coinfection: Table 1.
Judith Bruchfeld, Margarida Correia‐Neves, Gunilla Källenius · 2015 · Cold Spring Harbor Perspectives in Medicine · 354 citations
Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) constitute the main burden of infectious disease in resource-limited countries. In the individual ho...
Incidence and Risk Factors for Immune Reconstitution Inflammatory Syndrome in an Ethnically Diverse HIV Type 1-Infected Cohort
Irani Ratnam, Chen‐Yuan Chiu, N-B Kandala et al. · 2006 · Clinical Infectious Diseases · 349 citations
Approximately one-quarter of patients who start HAART experience an IRIS event. The majority are dermatological, in particular genital herpes and warts. Patients with advanced immunodeficiency at H...
Immune Reconstitution in HIV‐Infected Patients
Hans H. Hirsch, Gilbert R. Kaufmann, Parham Sendi et al. · 2004 · Clinical Infectious Diseases · 325 citations
The prognosis of patients infected with human immunodeficiency virus (HIV) type 1 has dramatically improved since the advent of potent antiretroviral therapies (ARTs), which have enabled sustained ...
Reading Guide
Foundational Papers
Start with Ratnam et al. (2006) for IRIS incidence and risk factors in diverse cohorts; Pawłowski et al. (2012) for TB-HIV coinfection burden; Murdoch et al. (2007) for clinical manifestations and treatments.
Recent Advances
Nahid et al. (2016) for TB treatment guidelines relevant to IRIS; Bruchfeld et al. (2015) for updated TB-HIV perspectives; Cain et al. (2010) for HIV-TB screening algorithms.
Core Methods
Cohort studies for incidence (Ratnam et al., 2006); consensus guidelines for management (Solovič et al., 2010; Nahid et al., 2016); symptom-based screening algorithms (Cain et al., 2010).
How PapersFlow Helps You Research Immune Reconstitution Inflammatory Syndrome
Discover & Search
Research Agent uses searchPapers and exaSearch to find IRIS papers like 'Incidence and Risk Factors for Immune Reconstitution Inflammatory Syndrome' by Ratnam et al. (2006), then citationGraph reveals TB-HIV links to Pawłowski et al. (2012), and findSimilarPapers uncovers cohort studies on ethnic risk factors.
Analyze & Verify
Analysis Agent applies readPaperContent to extract IRIS incidence rates from Ratnam et al. (2006), verifies claims with CoVe against Bruchfeld et al. (2015), and runs PythonAnalysis on cohort data for statistical risk modeling with GRADE grading for evidence strength in TB-IRIS predictors.
Synthesize & Write
Synthesis Agent detects gaps in corticosteroid efficacy across Murdoch et al. (2007) and Ratnam et al. (2006), flags contradictions in ART timing from Cain et al. (2010); Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to generate a review manuscript with exportMermaid for IRIS pathway diagrams.
Use Cases
"Analyze IRIS incidence rates and risk factors from diverse HIV cohorts"
Research Agent → searchPapers('IRIS HIV cohort') → Analysis Agent → readPaperContent(Ratnam 2006) → runPythonAnalysis(pandas cohort stats, matplotlib risk plots) → CSV export of 25% incidence verification.
"Write a LaTeX review on TB-IRIS management guidelines"
Synthesis Agent → gap detection(TB-IRIS steroids) → Writing Agent → latexEditText(draft sections) → latexSyncCitations(Pawłowski 2012, Murdoch 2007) → latexCompile(PDF) → researcher gets formatted manuscript.
"Find code for modeling IRIS predictors in HIV-TB patients"
Research Agent → paperExtractUrls(IRIS stats papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect(survival models) → researcher gets Python scripts for risk factor simulation.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ TB-HIV papers: searchPapers → citationGraph → GRADE grading → structured IRIS report. DeepScan applies 7-step analysis with CoVe checkpoints to verify Ratnam et al. (2006) risk factors against Pawłowski et al. (2012). Theorizer generates hypotheses on ART timing from Cain et al. (2010) and Murdoch et al. (2007).
Frequently Asked Questions
What defines Immune Reconstitution Inflammatory Syndrome?
IRIS is a paradoxical worsening of treated or untreated infections after ART initiation due to immune recovery in HIV patients (Murdoch et al., 2007).
What are common IRIS methods for diagnosis?
Diagnosis relies on clinical worsening post-ART despite pathogen treatment, excluding alternatives; risk stratification uses CD4 counts at baseline (Ratnam et al., 2006).
What are key papers on IRIS?
Ratnam et al. (2006, 349 citations) detail incidence and risks; Murdoch et al. (2007, 297 citations) review manifestations and treatments; Pawłowski et al. (2012, 748 citations) cover TB-HIV context.
What open problems exist in IRIS research?
Optimal ART-TB treatment timing, precise risk prediction models, and corticosteroid regimens for TB-IRIS lack consensus (Cain et al., 2010; Nahid et al., 2016).
Research Infectious Diseases and Tuberculosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Immune Reconstitution Inflammatory Syndrome with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers